We are live on
!
Find out more
DCM
DAFNA Capital Management Portfolio holdings
AUM
$440M
1-Year Est. Return
109.12%
This Fund
S&P 500
This Quarter
Est. Return
+13.9%
1 Year Est. Return
+109.12%
3 Year Est. Return
+239.59%
5 Year Est. Return
+227.89%
10 Year Est. Return
+3,611.91%
AUM
$366M
AUM Growth
+$32.2M
(+9.7%)
Cap. Flow
+$2.36M
Cap. Flow
% of AUM
0.64%
Top 10 Holdings %
Top 10 Hldgs %
49.41%
Holding
80
New
7
Increased
18
Reduced
15
Closed
7
Top Buys
| 1 |
DAWN
Day One Biopharmaceuticals
DAWN
|
+$6.62M |
| 2 |
TSVT
2seventy bio
TSVT
|
+$5.26M |
| 3 |
Tandem Diabetes Care
TNDM
|
+$3.54M |
| 4 |
Kura Oncology
KURA
|
+$2.93M |
| 5 |
MRUS
Merus
MRUS
|
+$2.21M |
Top Sells
| 1 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$7.8M |
| 2 |
CSII
Cardiovascular Systems, Inc.
CSII
|
+$5.7M |
| 3 |
APLS
Apellis Pharmaceuticals
APLS
|
+$3.81M |
| 4 |
Biohaven
BHVN
|
+$3.69M |
| 5 |
DICE
DICE Therapeutics, Inc. Common Stock
DICE
|
+$2.07M |
Sector Composition
| 1 | Healthcare | 82.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
State Street SPDR S&P Biotech ETF
XBI
$10.5B
| $47M | 12.85% |
565,000
-5,000
| -0.9% | -$418K |
|
|
ISEE
2
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $24.1M | 6.59% |
612,975
| – | – |
|
3
Stereotaxis
STXS
$161M
| $20.9M | 5.72% |
13,680,554
| – | – |
|
|
BPMC
4
DELISTED
Blueprint Medicines
BPMC
| $15.9M | 4.35% |
251,521
-9,714
| -4% | -$528K |
|
5
Revolution Medicines
RVMD
$39.2B
| $13.7M | 3.75% |
512,285
-63,500
| -11% | -$1.56M |
|
6
iShares Biotechnology ETF
IBB
$9.2B
| $13M | 3.56% |
102,500
| – | – |
|
7
Ascendis Pharma A/S
ASND
$17.4B
| $12.1M | 3.3% |
135,212
| – | – |
|
|
MORF
8
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $11.9M | 3.24% |
206,748
+27,281
| +15% | +$1.42M |
|
9
IDEAYA Biosciences
IDYA
$3.54B
| $11.3M | 3.08% |
479,820
+11,462
| +2% | +$236K |
|
10
Cytokinetics
CYTK
$11.2B
| $10.9M | 2.97% |
332,734
+56,239
| +20% | +$2.08M |
|
11
Xenon Pharmaceuticals
XENE
$6.52B
| $10.8M | 2.95% |
280,538
-35,554
| -11% | -$1.41M |
|
|
MRUS
12
DELISTED
Merus
MRUS
| $10.1M | 2.77% |
384,870
+100,872
| +36% | +$2.21M |
|
13
Syndax Pharmaceuticals
SNDX
$2.12B
| $9.44M | 2.58% |
450,873
+3,800
| +0.8% | +$79.1K |
|
|
KRTX
14
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $9.15M | 2.5% |
42,173
-36,400
| -46% | -$7.8M |
|
15
DexCom
DXCM
$28.6B
| $8.68M | 2.37% |
67,552
| – | – |
|
|
SAGE
16
DELISTED
Sage Therapeutics
SAGE
| $8.48M | 2.32% |
180,306
| – | – |
|
17
Neurocrine Biosciences
NBIX
$17.2B
| $7.04M | 1.92% |
74,615
| – | – |
|
18
AtriCure
ATRC
$1.76B
| $6.2M | 1.69% |
125,529
| – | – |
|
|
DAWN
19
DELISTED
Day One Biopharmaceuticals
DAWN
| $6.05M | 1.66% |
+507,100
| New | +$6.62M |
|
|
DICE
20
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $5.93M | 1.62% |
127,585
-60,000
| -32% | -$2.07M |
|
21
Nurix Therapeutics
NRIX
$2.45B
| $5.56M | 1.52% |
556,695
-10,000
| -2% | -$102K |
|
|
KALV
22
DELISTED
KalVista Pharmaceuticals
KALV
| $5.5M | 1.5% |
611,032
-5,000
| -0.8% | -$46.1K |
|
|
TSVT
23
DELISTED
2seventy bio
TSVT
| $5.02M | 1.37% |
+496,416
| New | +$5.26M |
|
24
Viking Therapeutics
VKTX
$4.38B
| $4.76M | 1.3% |
293,655
-25,500
| -8% | -$534K |
|
25
Accuray
ARAY
$32.8M
| $4.73M | 1.29% |
1,222,358
| – | – |
|
Similar funds
FGWP
STCG
SCP
CAAM
AWM
HCM
CPW
DWML